Stay updated on Imatinib in Recurrent Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.

Latest updates to the Imatinib in Recurrent Psoriasis Clinical Trial page
- Check5 days agoChange DetectedThe differences shown in the screenshots seem to be cosmetic UI/layout changes without changes to the study's core details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference4%

- Check34 days agoChange DetectedUpdates the page version from v3.0.2 to v3.1.0, indicating a new release.SummaryDifference0.1%

- Check48 days agoChange DetectedVersion bumped to v3.0.2 and the Back to Top link was removed; no substantive changes to core content, pricing, or availability.SummaryDifference0.2%

- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as updates to medical terms related to diseases and compounds. Notably, the version has been updated from v2.16.12 to v3.0.0.SummaryDifference4%

Stay in the know with updates to Imatinib in Recurrent Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.